Task: Answer the multiple choice question.
Question: Which compound exhibits a -67.164% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. CCOC(=O)CN1C(=O)C(O)(CC(=O)c2ccco2)c2ccccc21
b. CCN1CCCC1Cn1cnc2c([nH]c3cccc(Cl)c32)c1=O
c. Cc1ccccc1OCC(=O)NCCC(=O)O
Answer: b. CCN1CCCC1Cn1cnc2c([nH]c3cccc(Cl)c32)c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN1CCCC1Cn1cnc2c([nH]c3cccc(Cl)c32)c1=O
CCN1CCCC1Cn1cnc2c([nH]c3cccc(Cl)c32)c1=O
9-chloro-3-[(1-ethylpyrrolidin-2-yl)methyl]-5H-pyrimido[5,4-b]indol-4-one